Subcutaneous Immunotherapy for Mouse in Adults

Summary

This is an open label trial of mouse allergenic extract administered by subcutaneous injection in adults with asthma and mouse sensitivity. The study is designed to evaluate: * the safety of this therapy when given by injection * biomarkers of the immune response and * whether the therapy would be effective in treating allergic asthma.

Timeline

Start

2015-10

Primary completion

2016-10

Completion

2016-10

Drugs

Indications